Ji Yibing, Zhang Qian, Li Hua, Chen Lixia, Wu Yuzhuo, Lin Sheng
College of Pharmacy, Shandong Second Medical University, Weifang, Shandong, 261053, People's Republic of China.
Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, People's Republic of China.
J Inflamm Res. 2025 Mar 27;18:4481-4495. doi: 10.2147/JIR.S504673. eCollection 2025.
Platelet factor 4 (PF4), also referred to as CXCL4, is a significant component of the C-X-C chemokine family, predominantly localized within the alpha granules of platelets. It is recognized for its anti-heparin and anti-angiogenic properties. However, the involvement of PF4 in inflammatory processes has not been extensively investigated. This article aims to explore the diverse functions of PF4 in the context of inflammatory diseases, emphasizing its potential dual regulatory roles across various immune cell types and pathological conditions. Recent research has enhanced our comprehension of PF4, revealing its production not only in platelets but also in macrophages and activated T cells, thereby extending its functional repertoire beyond its conventional roles. Consequently, this review provides a thorough analysis of PF4's influence on inflammatory diseases and offers perspectives and recommendations for future research endeavors.
血小板因子4(PF4),也称为CXCL4,是C-X-C趋化因子家族的重要组成部分,主要定位于血小板的α颗粒内。它因其抗肝素和抗血管生成特性而被认可。然而,PF4在炎症过程中的作用尚未得到广泛研究。本文旨在探讨PF4在炎症性疾病中的多种功能,强调其在各种免疫细胞类型和病理条件下潜在的双重调节作用。最近的研究增进了我们对PF4的理解,揭示了它不仅在血小板中产生,还在巨噬细胞和活化的T细胞中产生,从而扩展了其功能范围,超越了其传统作用。因此,本综述对PF4对炎症性疾病的影响进行了全面分析,并为未来的研究工作提供了观点和建议。